Tin tức & Cập nhật
Xem bài viết Hô hấp
Xem
Chỉ hiển thị Multimedia

Zongertinib shows promise in Asians with advanced HER2-mutant NSCLC
18 Jan 2026
bởiStephen Padilla
Treatment with zongertinib in Asian patients with advanced HER2-mutant nonsmall cell lung cancer (NSCLC), who have received prior systemic therapy, delivers robust efficacy and elicits an acceptable safety profile, consistent with the overall global analysis, reports a China study.
18 Jan 2026

Maternal asthma may raise congenital heart defect risk in offspring
15 Jan 2026
bởiStephen Padilla
Asthma and allergic tendency in mothers appear to elevate the risk of congenital heart defect (CHD) in their children, suggests a study, noting that nonallergic asthma also contributes to such risk.
15 Jan 2026

Ivonescimab trumps tislelizumab for squamous NSCLC in HARMONi-6
06 Jan 2026
bởiAudrey Abella
In the phase III HARMONi-6 trial, ivonescimab plus chemotherapy significantly improved progression-free survival (PFS) compared with tislelizumab plus chemo as first-line treatment for individuals with advanced squamous non-small cell lung cancer (NSCLC).
06 Jan 2026






